Earnings Preview: What To Expect From Moderna’s ReportBarchart Option·21 hours agoMRNA-1.81%MRNX-3.51%
Regulatory Momentum for Daraxonrasib and RAS Pipeline Upside Support Charles Zhu’s Buy Rating on RVMD with Unchanged $263 Price TargetTip Ranks·1 day ago, 04:35 PMRVMD+3.13%
Revolution Medicines says FDA accepts daraxonrasib NDA for previously treated metastatic pancreatic cancerPUBT·1 day ago, 03:11 PMRVMD+3.13%
Moderna (MRNA) Adds Finance Veteran To Its Board, Is The Stock Fully Valued?Simplywall·1 day ago, 08:14 AMMRNA-1.81%MRNX-3.51%
Incyte Corp. Stock Outperforms Competitors On Strong Trading DayMarketWatch Automated·2 days ago, 04:03 PMINCY+0.78%
16:26 ETERAS INVESTOR DEADLINE: Erasca, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit - HBSSprnewswire·2 days ago, 03:28 PMERAS-0.87%RVMD+3.13%
Halozyme and Incyte sign licence agreement for INCA033989 formulationsPharmaceutical Business Review·Jul 21 at 04:15 AMINCY+0.78%HALO+3.88%
FairJourney Bio Announces Scientific Program and Leadership for The Antibody Series 2026MorningStar·Jul 21 at 04:04 AMMRNA-1.81%MRNX-3.51%
Top Incyte Executives Quietly Lock In Profits With Fresh Stock SalesTip Ranks·Jul 20 at 09:01 PMINCY+0.78%
Incyte Corp. Stock Underperforms Monday When Compared To CompetitorsMarketWatch Automated·Jul 20 at 04:04 PMINCY+0.78%
Incyte EVP, Head of U.S. Commercial Issa Mohamed Khairie sells 1,093 shares for $125,705.93PUBT·Jul 20 at 03:10 PMINCY+0.78%
Halozyme partners with Incyte on ENHANZE subcutaneous formulation for INCA033989 antibodyPUBT·Jul 20 at 07:05 AMINCY+0.78%HALO+3.88%
Trade Alert: Executive VP Of Incyte Steven Stein Has Sold StockSimplywall·Jul 18 at 08:10 AMINCY+0.78%
4 Health Care Stocks Whale Activity In Today’s Sessionbenzinga_article·Jul 17 at 12:35 PMTEM-2.02%RVMD+3.13%